Generics BulletinWockhardt has confirmed earlier reports that it will exit its loss-making US generics pharmaceutical business and file for voluntary liquidation of its US subsidiaries, in part to focus on higher-va
Generics BulletinA string of strategic deals including with Sanofi , Bayer and Nestle marked the last couple of months at Dr. Reddy's Laboratories Ltd. , as the Indian firm plugs portfolio gaps and builds moment
ScripA string of strategic deals including with Sanofi , Bayer and Nestle marked the last couple of months at Dr. Reddy's Laboratories Ltd. , as the Indian firm plugs portfolio gaps and builds moment
ScripIndia’s pharmaceutical companies are likely to see FY24 year-on-year growth in US market revenues slow down to 6-8% from 16% seen in FY23, based on its coverage universe of 25 companies, rating agency